IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Halozyme Therapeutics Inc

Q2 2026 vs Q3 2026

Comparing institutional holders between quarters

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
AlphaCore Capital LLC
DECREASED
Shares250 from 330
Change-80 (-24%)
Value$462.5K (-$89.1K)
Filed 2026-11-04
Status
AlphaCore Capital LLC
DECREASED250330-80-24%$551.6K$462.5K-$89.1K2026-11-04
Showing 1 of 1 institutions